In the last 12 months, insiders at Polaryx Therapeutics, Inc. ($PLYX) filed 1 transactions with the SEC: 1 open-market purchases totaling $7,991 and 0 sales totaling $0. Net insider sentiment: net buying.
Polaryx Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Landis G. Michael (Chief Financial Officer) — 1 transaction totaling $7,991
View all SEC Filings for Polaryx Therapeutics, Inc. (PLYX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Landis G. Michael | Chief Financial Officer | P | Common Stock | 2867 | $2.79 | 228,225.0000 | 0 | 1.27% | 0.00% |